Global Vagus Nerve Stimulators Market to Surpass US$ 1,251.9 Million by 2030 - Coherent Market Insights

06 Jun 2022
www.prnewswire.com
CollaborateAcquisition
SEATTLE, June 6, 2022 /PRNewswire/ -- According to
vagus nerve stimulators market is estimated to be valued at
US$  628.3 million in
2022 and is expected to exhibit a
CAGR of
9.0% over the forecast period
(2022-2030).
Key Trends and Analysis of the Global Vagus Nerve Stimulators Market:
Key trends in the market include increasing prevalence of neurological disorders such as epilepsy, depression, anxiety, migraine, among others; increasing approval of novel products, and increasing collaborations, acquisitions, and partnerships among key players. These key trends are expected to aid in growth of the global vagus nerve stimulators market.
According to an article published by The Scientific World Journal, a peer-reviewed, open access journal, in June 2020, it is estimated that migraine prevalence ranged between 2.6% and 32% among the general population in Arab countries (such as Bahrain, Iraq, Jordan, etc.), in 2019. The same source also estimates that the prevalence of migraine headache among school children of age group 6 to 18 years ranged between 7.1% and 13.7% and between 12.2% and 27.9% in medical university students in Arab countries in 2019.
Moreover, increasing approvals of novel
vagus nerve stimulator products are expected to drive the market growth over the forecast period. For instance, in January 2022, electroCore, Inc., a U.S. based medical technology company announced that it has received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its gammaCore Non-Invasive Vagus Nerve Stimulation(nVNS) for the treatment of post-traumatic stress disorder (PTSD).
Furthermore, key players operating in the global
vagus nerve stimulators market are focusing on adoption of inorganic growth strategies such as distributor agreements, acquisitions, collaborations, in order to expand their market presence in the global market. For instance, in February 2021, electroCore, Inc. announced that it has entered into a distributive agreement with Medistar, an Australia based independent medical device distributor, distribution of electroCore, Inc.'s gammaCore Sapphire non-invasive vagus nerve stimulator (nVNS) in Australia.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2514
Key Market Takeaways:
The global vagus nerve stimulators market is expected to exhibit a CAGR of 5.1% over the forecast period, owing to rising research in development of novel vagus nerve stimulators. For instance, in February 2021, SetPoint Medical, a U.S. based biotechnology company announced that it has enrolled the first patient in its Investigational Device Exemption (IDE) study, which aims to evaluate SetPoint's proprietary bioelectronics device, a vagus nerve stimulator for treatment of rheumatoid arthritis.
Among applications, epilepsy segment is expected to account for the largest market share in 2022, owing to high incidence of epilepsy. For instance, according to data published by the World Health Organization (WHO) in February 2022, it was estimated that epilepsy is the most common neurological disease in the world, with around 50 million people suffering from epilepsy, globally, in 2019.
Key players operating in the global vagus nerve stimulators market include
Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2514
Detailed Segmentation:
Global Vagus Nerve Stimulators Market, By Product Type:
Global Vagus Nerve Stimulators Market, By Application:
Others (Crohn's disease, Dyskinesia, among others)
Global Vagus Nerve Stimulators Market, By End User:
Hospitals
Others (Research Institutions, Ambulatory Surgical Centers, among others)
Global Vagus Nerve Stimulators Market, By Region:
North America
By Country:
U.S.
Canada
Europe
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
By Country:
GCC Countries
Israel
South Africa
Rest of Middle East & Africa
Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/2514
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
SOURCE Coherent Market Insights
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.